Psoriatic Arthritis News

Tofacitinib Shows Promise in Psoriatic Arthritis - Medscape



Medscape
 
Tofacitinib Shows Promise in Psoriatic Arthritis 
Medscape
Data from two clinical trials have shown that the orally administered Janus kinase inhibitor tofacitinib is more effective than placebo for treating patients with active psoriatic arthritis (PsA) and inadequate response to treatment with conventional ...

 


Survey: Psoriatic arthritis sufferers often feel frustrated - Tribune-Review



Survey: Psoriatic arthritis sufferers often feel frustrated 
Tribune-Review
Psoriatic arthritis is an inflammatory disease closely related to and most often co-occurring with psoriasis. The most commonly reported symptom among respondents was fatigue (94 percent), but other symptoms include pain, swelling and stiffness of the ...
Psoriatic Arthritis (PsA) Treatments Market ? New Business Opportunities and Investment Research Report 2022 Medgadget (blog)
Psoriatic Arthritis (PsA) Treatment Market Value Chain and Forecast 2017-2027 Find Market Research By Abhishek Budholiya (press release) (blog)

all 4 news articles » 


Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis ... - Managed Care magazine



Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis ... 
Managed Care magazine
The FDA has approved golimumab (Simponi Aria, Janssen Biotech, Inc.) for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing ...
FDA Approves Golimumab for 2 New Indications MD Magazine
Janssen (JNJ) Receives Two US FDA Approvals For SIMPONI ARIA For Treatment of Adults With Active PsA or Active ... StreetInsider.com

all 3 news articles » 


Tofacitinib Efficacy Investigated in Patients With Psoriatic Arthritis - Monthly Prescribing Reference



Tofacitinib Efficacy Investigated in Patients With Psoriatic Arthritis 
Monthly Prescribing Reference
(HealthDay News) ? For patients with active psoriatic arthritis who have an inadequate response to tumor necrosis factor (TNF) inhibitors or to conventional synthetic disease-modifying antirheumatic drugs (DMARDs), tofacitinib is superior to placebo, ...

 


Novel Interleukin Inhibitors Efficacious for Psoriatic Arthritis - Rheumatology Advisor



Rheumatology Advisor
 
Novel Interleukin Inhibitors Efficacious for Psoriatic Arthritis 
Rheumatology Advisor
Inhibitors of interkeukin-6 (IL-6; clazakizumab), IL-12/23 (ustekinumab), and IL-17A (secukinumab, brodalumab, and ixekizumab) were shown to be effective and generally well tolerated for the treatment of psoriatic arthritis (PsA) in a systematic review ...

 


As Taltz growth stalls, Lilly looks ahead to psoriatic arthritis expansion - FiercePharma



FiercePharma
 
As Taltz growth stalls, Lilly looks ahead to psoriatic arthritis expansion 
FiercePharma
Eli Lilly is counting on psoriasis med Taltz to drive U.S. volume growth. But lately, that growth has stalled. New prescriptions for the next-gen med have stayed relatively flat over the last couple of months, Evercore ISI analyst Umer Raffat pointed ...

 


Biomarkers of Peripheral and Axial Arthritis in Psoriatic Disease - Rheumatology Advisor



Biomarkers of Peripheral and Axial Arthritis in Psoriatic Disease 
Rheumatology Advisor
The Axial Disease in Psoriatic Arthritis Study (ADIPSA) was a cross-sectional comparative study that examined levels of 4 biomarkers ? dickkopf 1 (Dkk-1), osteoprotegerin, macrophage colony stimulating factor (M-CSF), and matrix metalloproteinase 3 ...

 


World Arthritis Day: What are rheumatoid and psoriatic arthritis and ... - Metro



Metro
 
World Arthritis Day: What are rheumatoid and psoriatic arthritis and ... 
Metro
World Arthritis Day will be celebrated on Thursday, October 12, and this year's theme is 'It's in your hands, take action.' In honouring World Arthritis Day it is ...

and more » 


How Your Diet Can Make Your Psoriasis Symptoms Worse?And What To Do About It - Prevention.com



Prevention.com
 
How Your Diet Can Make Your Psoriasis Symptoms Worse?And What To Do About It 
Prevention.com
Sadly, the emotional toll of psoriasis is only one aspect of its challenges. Psoriasis patients are also at greater risk of additional autoimmune illnesses, including rheumatoid arthritis, another form of arthritis known as psoriatic arthritis, and ...

 


Psoriatic Arthritis' Impact Not Always Visible or Understood, Patients ... - Marketwired (press release)



Psoriatic Arthritis' Impact Not Always Visible or Understood, Patients ... 
Marketwired (press release)
PHILADELPHIA, PA--(Marketwired - October 12, 2017) - Explaining the "invisible" aspects of psoriatic arthritis often presents a challenge, according to "Psoriatic ...

and more »